BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25018152)

  • 1. The politics of harm reduction in federal prisons.
    Watson TM
    Int J Drug Policy; 2014 Sep; 25(5):916-23. PubMed ID: 25018152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Elusive Goal of Drug-Free Prisons.
    Watson TM
    Subst Use Misuse; 2016 Jan; 51(1):91-103. PubMed ID: 26757196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The furthest left behind: the urgent need to scale up harm reduction in prisons.
    Sander G; Murphy F
    Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The place of syringe exchange programs in reducing harm in Canadian prisoners].
    Orsi MM; Brochu S
    Can J Public Health; 2009; 100(1):29-31. PubMed ID: 19263972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "It Goes on Everywhere": Injection Drug Use in Canadian Federal Prisons.
    van der Meulen E
    Subst Use Misuse; 2017 Jun; 52(7):884-891. PubMed ID: 28426354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Introduction of Prison Needle and Syringe Programs in Canadian Federal Prisons.
    Peternelj-Taylor C
    J Forensic Nurs; 2018; 14(3):123-125. PubMed ID: 30130313
    [No Abstract]   [Full Text] [Related]  

  • 7. Injecting substance use in prisons in the United States: a case for needle exchange programs.
    Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
    Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Global State of Harm Reduction in Prisons.
    Sander G; Shirley-Beavan S; Stone K
    J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
    Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
    Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Senior Management Perspective on the Policy Debate of Needle and Syringe Exchange Program Provision in Irish Prisons.
    Rosalim JP
    J Correct Health Care; 2020 Jan; 26(1):27-35. PubMed ID: 31983260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative government scuttles needle exchange.
    Kondro W
    CMAJ; 2007 Jan; 176(3):308. PubMed ID: 17261817
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of harm reduction in prisons in seven European countries.
    Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
    Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs, prisons, and harm reduction.
    Hughes R
    J Health Soc Policy; 2003; 18(2):43-54. PubMed ID: 15189795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.
    Philbin MM; Mantsios A; Lozada R; Case P; Pollini RA; Alvelais J; Latkin CA; Magis-Rodriguez C; Strathdee SA
    Int J Drug Policy; 2009 Jul; 20(4):329-35. PubMed ID: 18963906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to sterile syringes for injecting drug users in New York City: politics and perception (1984-2010).
    Heller D; Paone D
    Subst Use Misuse; 2011; 46(2-3):140-9. PubMed ID: 21303234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legal prison tattooing centers: viable health policy initiative?
    Awofeso N
    J Public Health Manag Pract; 2010; 16(3):240-4. PubMed ID: 20357610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm reduction programmes in the Asia--Pacific Region.
    Reid G; Devaney ML; Baldwin S
    Drug Alcohol Rev; 2008 Jan; 27(1):95-8. PubMed ID: 18034387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug use in prisons in Kyrgyzstan: a study about the effect of health promotion among prisoners.
    Moller LF; van den Bergh BJ; Karymbaeva S; Esenamanova A; Muratalieva R
    Int J Prison Health; 2008; 4(3):124-33. PubMed ID: 18698527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.